School of Population Health, University of New South Wales, Sydney, Australia.
Research School of Population Health, Australian National University, Canberra, Australia.
Res Social Adm Pharm. 2022 Nov;18(11):3974-3979. doi: 10.1016/j.sapharm.2022.07.001. Epub 2022 Jul 9.
Pharmacists play a key role in tackling the global public health threat of antimicrobial resistance (AMR) through contributing to antimicrobial stewardship (AMS) practices. Professional pharmacy organisations describe this AMS role in position statements. Understanding how this role is described, including the why and potential impact is a first step to understanding how this issue is described to the profession, and framed in advocacy.
To examine how pharmacy's role in optimising antimicrobial use is articulated in pharmacy professional organisations' position statements.
Publicly available AMR position statements were sourced between February 2021 and May 2021 from the available websites of all International Pharmaceutical Federation (FIP) member organisations, supplemented by a general engine search. Descriptive analysis was conducted with a focus on four key themes of interest: 1) rationale for pharmacists' involvement in AMS) 2) characterisation of pharmacists' AMS role; 3) perceived impact of pharmacists' involvement in AMS; and 4) perceived enablers and/or barriers to AMS involvement.
17 position statements were sourced and analysed. Professional pharmacy organisations appear to focus on characterising pharmacists as advisors and educators as their primary role in AMS, with this function supported by their medication knowledge and accessibility as a health service. Specific settings, such as hospital or community pharmacy, were often highlighted in the documents, and were associated with the framing of the capacity and nature of pharmacists' involvement in AMS. However, the limitations of pharmacists and their positions were not discussed.
There is an opportunity for future research to explore the concordance between the expectation of pharmacists' involvement in AMS as outlined in these position statements, with the reality of their involvement. This is of importance in the primary care setting, as a key access point to antimicrobials globally.
药剂师通过参与抗菌药物管理(AMS)实践,在应对全球公共卫生威胁——抗菌药物耐药性(AMR)方面发挥着关键作用。专业的药学组织在立场声明中描述了这一 AMS 角色。了解这一角色是如何被描述的,包括原因和潜在影响,是了解这一问题是如何向专业人员描述并在宣传中构建的第一步。
检查药学在优化抗菌药物使用方面的作用是如何在药学专业组织的立场声明中阐述的。
在 2021 年 2 月至 2021 年 5 月期间,从国际药学联合会(FIP)所有成员组织的现有网站上获取了公开的 AMR 立场声明,并通过一般引擎搜索进行了补充。采用描述性分析方法,重点关注四个感兴趣的主题:1)药剂师参与 AMS 的基本原理;2)药剂师 AMS 角色的特征;3)药剂师参与 AMS 的预期影响;4)参与 AMS 的预期促进因素和/或障碍。
共获取并分析了 17 份立场声明。专业药学组织似乎将药剂师主要定位于 AMS 中的顾问和教育者,他们的药物知识和作为卫生服务的可及性支持这一职能。这些文件通常强调了特定的环境,如医院或社区药房,并将药剂师在 AMS 中的参与能力和性质与这些环境联系起来。然而,并没有讨论药剂师及其职位的局限性。
未来的研究有机会探索这些立场声明中概述的药剂师参与 AMS 的期望与他们实际参与之间的一致性。这在初级保健环境中尤为重要,因为这是全球获得抗菌药物的主要途径。